Navigation Links
uniQure Named to MIT Technology Review's 2013 50 Disruptive Companies List Recognizing World's Most Innovative Companies
Date:2/20/2013

CAMBRIDGE, Massachusetts and AMSTERDAM, February 20, 2013 /PRNewswire/ --

uniQure has been identified in the field of biomedicine as one of 2013's 50 Disruptive Companies, MIT Technology Review's annual list of the world's most innovative technology companies.  The honorees are nominated by MIT Technology Review's editors, who look for companies that have demonstrated original and valuable technology over the last year, are bringing that technology to market at significant scale, and are clearly influencing their competitors. Spanning energy and materials, Internet and digital media, computing and communications, biomedicine, and transportation, the 50 companies on the list represent the disruptive innovations most likely to change our lives.

     (Logo: http://photos.prnewswire.com/prnh/20130220/595152)

Jason Pontin , publisher and editor in chief of MIT Technology Review, states, "The pace at which technology changes is astounding. This issue celebrates organizations at the forefront, displaying 'disruptive innovation' that will prove to surpass the competition, transform an industry, and change our lives.  uniQure proves they are one of those companies by restoring the promise of gene therapy with the approval to treat rare metabolic disorders."

uniQure is the world leader in the development of human gene based therapies. uniQure's Glybera, a gene therapy for the treatment of lipoprotein lipase deficiency was approved in the European Union in November 2012, and is the first approved gene therapy in the Western world.

"We are honored by the recognition of MIT Technology Review," says J
'/>"/>

SOURCE uniQure
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. uniQure Collaborates with UCSF on GDNF Gene Therapy in Parkinsons Disease
2. uniQure Appoints Philip Astley-Sparke President US
3. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
4. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual StevieĀ® Awards for Women in Business
5. Sequenom Named to NASDAQ Global Select Market
6. U of Toronto experiment named top breakthrough of 2011 by Physics World
7. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
8. Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine
9. Royals Batter Billy Butler Named Hutch Award Winner
10. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
11. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... Look inside the new Preferred Solutions® ... lab, from fluid handling to instruments to supplies. Many ... you order. , Preferred Solutions features a full ... L/S® model for precise flow control and dispensing to ...
(Date:1/15/2014)... and SAN JOSE, California , January ... company developing antibody-drug conjugates for cancer, today announced the appointment ... Directors. Dr Reynolds has over 20 years, development experience gained ... at Seattle Genetics. "I am delighted to welcome ...
(Date:1/15/2014)... January 15, 2014 This webinar will ... and clinical safety assessment in biosimilars. , Regulatory frameworks ... biosimilar drug development, however the complex nature of biopharmaceuticals ... safety and efficacy extremely challenging. Based on the specific ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2
... , ROCKVILLE, Md. , Jan. ... today that it has successfully completed a pre-clinical safety and ...  Results from this study are needed to support an Investigational ... protein particle based RSV (RSV-F) vaccine candidate into clinical development. ...
... ... syndicated radio host Dr. Ken Kronhaus to educate about the need for vascular screening in ... carotid arteries for potential causes of stroke, the abdominal aorta for aneurysms, and the legs ... ...
... new antimalarial drugs after discovering the normal function of ... protein, which causes resistance to the front-line drug chloroquine. ... the malarial chloroquine-resistance factor. The study examined transporter ... cell. The genes for these proteins are present in ...
Cached Biology Technology:NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate 2NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate 3NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate 4NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate 5Life Line Screening and Dr. Ken Kronhaus Work Together to Educate People About Vascular Screening 2Life Line Screening and Dr. Ken Kronhaus Work Together to Educate People About Vascular Screening 3Discovery provides new drug targets for malaria cure 2
(Date:4/22/2014)... Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered ... treat most neurodegenerative diseases that are characterized by ... diseases. These molecules are based on what the ... GAIM, which recognizes a characteristic common to many ... misfolded protein. This approach provides NeuroPhage with an ...
(Date:4/22/2014)... developing countries could be monitored from birth to ... a new technique piloted by a London-based university ... be visualised and tracked more quickly, more accurately ... near infra-red spectroscopy (fNIRS), compared to the behavioural ... , Professor Clare Elwell, Professor of Medical ...
(Date:4/21/2014)... HOUSTON, April 21, 2014 Performing brain research that ... advances, University of Houston (UH) junior Khanh (Kate) Nguyen ... science students. A double major in mathematics and physics, ... M. Goldwater Scholarship. , One of the most ... provides funding to sophomore and junior students majoring in ...
Breaking Biology News(10 mins):NeuroPhage discovers GAIM-changing molecules to combat Alzheimer's and related diseases 2NeuroPhage discovers GAIM-changing molecules to combat Alzheimer's and related diseases 3First brain images of African infants enable research into cognitive effects of nutrition 2UH student named Goldwater Scholar, 2 more receive honorable mention 2UH student named Goldwater Scholar, 2 more receive honorable mention 3UH student named Goldwater Scholar, 2 more receive honorable mention 4
... and its consequent lack of access to care appears ... may partly explain the mortality disparity between African-Americans and ... Third AACR Conference on The Science of Cancer Health ... die within four years compared to white patients after ...
... African-American women with breast cancer living in Washington, D.C., ... of insurance type, socioeconomic status and cancer characteristics such ... an associate professor of epidemiology at The George Washington ... the impact of race and socioeconomic status on health ...
... ,Cincinnati, (OH) - The International Rett Syndrome Foundation ... $1.5M in research grants, bringing the 2010 total to ... that moves treatments for Rett syndrome a step closer ... private source of Rett syndrome research funding and with ...
Cached Biology News:Lack of private health insurance impacted cancer survival 2Racial differences in breast cancer treatment persist despite similar economics 2Research becomes a reality for Rett syndrome through new funding 2Research becomes a reality for Rett syndrome through new funding 3Research becomes a reality for Rett syndrome through new funding 4
Animal Origin Free...
IHC Detection Kit (Broad Spectrum AEC)....
...
... Modification Services ,,GenScript offers many ... and antibody fragmentation. Labeling antibodies with ... visualization and quantitation of the target ... preferable to use only the antigen-binding ...
Biology Products: